Literature DB >> 17322075

Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.

Janet L Ingles1, Denise C Boulton, John D Fisk, Kenneth Rockwood.   

Abstract

BACKGROUND AND
PURPOSE: Neuropsychological changes that precede a diagnosis of vascular cognitive impairment (VCI) and the differences between preclinical VCI and Alzheimer disease (AD) are not well understood. We compared the neuropsychological performances of people with incident VCI, incident AD, and no cognitive impairment (NCI) 5 years before their clinical diagnoses.
METHODS: The Canadian Study of Health and Aging is a prospective, cohort study of 10,263 randomly selected persons age 65 years or older. We studied 332 individuals who had completed a battery of neuropsychological tests and were diagnosed with NCI at baseline. After 5 years, 41 were diagnosed with VCI, 25 with AD, and 266 with NCI.
RESULTS: At baseline, the incident-VCI group performed worse on a wide range of neuropsychological tests compared with the NCI group. A test of abstract reasoning was selectively low in the incident-VCI group, relative to both the incident-AD and NCI groups. The incident-AD group performed worse at baseline on memory tests compared with incident-VCI and NCI groups.
CONCLUSIONS: This study suggests a preclinical phase may exist in VCI that differs from that in AD. Neuropsychological measures may aid the design of preventive strategies for VCI.

Entities:  

Mesh:

Year:  2007        PMID: 17322075     DOI: 10.1161/01.STR.0000259716.04739.60

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.

Authors:  Ellen Grober; Charles B Hall; Richard B Lipton; Alan B Zonderman; Susan M Resnick; Claudia Kawas
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

2.  Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort.

Authors:  K Narasimhalu; S Ang; D A De Silva; M-C Wong; H-M Chang; K-S Chia; A P Auchus; C Chen
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

3.  Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial.

Authors:  Lewis H Kuller; Karen L Margolis; Sarah A Gaussoin; Nick R Bryan; Diana Kerwin; Marian Limacher; Sylvia Wassertheil-Smoller; Jeff Williamson; Jennifer G Robinson
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-03       Impact factor: 3.738

4.  Impact of repetitive transcranial magnetic stimulation on post-stroke dysmnesia and the role of BDNF Val66Met SNP.

Authors:  Haitao Lu; Tong Zhang; Mei Wen; Li Sun
Journal:  Med Sci Monit       Date:  2015-03-14

5.  A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile.

Authors:  Yi Lao; Binh Nguyen; Sinchai Tsao; Niharika Gajawelli; Meng Law; Helena Chui; Michael Weiner; Yalin Wang; Natasha Leporé
Journal:  Neuroimage Clin       Date:  2016-12-28       Impact factor: 4.881

6.  The inclusion of cognition in vascular risk factor clinical practice guidelines.

Authors:  Kenneth Rockwood; Laura E Middleton; Paige K Moorhouse; Ingmar Skoog; Sandra E Black
Journal:  Clin Interv Aging       Date:  2009-11-18       Impact factor: 4.458

7.  Cognitive Impairment After Stroke.

Authors:  Pushpendra Nath Renjen; Charu Gauba; Dinesh Chaudhari
Journal:  Cureus       Date:  2015-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.